BG Medicine Inc
OTC:BGMD
BG Medicine Inc
OTC:BGMD
Price:
0.0001 USD
Market Closed
Updated:
May 5, 2024
BG Medicine Inc
Cash from Financing Activities
|
BG Medicine Inc
Cash from Financing Activities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BG Medicine Inc
OTC:BGMD
|
Cash from Financing Activities
$1.1m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Financing Activities
-$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Financing Activities
-$144m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Financing Activities
-$859.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Financing Activities
-$382m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is BG Medicine Inc's Cash from Financing Activities?
Cash from Financing Activities
1.1m
USD
1.1m
USD
Based on the financial report for Dec 31, 2015, BG Medicine Inc's Cash from Financing Activities amounts to 1.1m USD.
What is BG Medicine Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-21%
-21%
Over the last year, the Cash from Financing Activities growth was -77%. The average annual Cash from Financing Activities growth rates for BG Medicine Inc have been -53% over the past three years , -21% over the past five years .
You don't have any saved screeners yet
